Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

Hedenus, Michael; Adriansson, Magnus; F. San Miguel, Jesús; H.H. Kramer, Mark; R. Schipperus, Martin; Juvonen, Eeva; Taylor, Kerry; Belch, Andrew; Altés, Albert; Martinelli, Giovanni; I. Watson, David; Matcham, James; Rossi, Gregory; J. Littlewood, Timothy

doi:10.1046/j.1365-2141.2003.04448.x

Public

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

Published in British Journal of Haematology • Jul 23, 2003

Authors:

Michael Hedenus

Magnus Adriansson

Jesús F. San Miguel

Abstract

This phase 3, randomized, double-blind, placebo-controlled study was designed to evaluate the efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies. Patients (n = 344) with lymphoma or myeloma received darbepoetin alfa 2.25 microg/kg or placebo s.c., once ...

Subject

Darbepoetin alfa

Medicine

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!